Incidence and costs of cardiac device infections: retrospective analysis using German health claims data

被引：41

作者：

Ludwig, Saskia ^{[1
]}

Theis, Cathrin ^{[2
]}

Brown, Ben ^{[3
]}

Witthohn, Andreas ^{[4
]}

Lux, Wolfram ^{[1
]}

Goette, Andreas ^{[5
]}

机构：

[1] HGC GesundheitsConsult GmbH, Dusseldorf, Germany

[2] Robert Bosch Krankenhaus, Zentrum Innere Med Kardiol 3, Auerbachstr 110, D-70376 Stuttgart, Germany

[3] Medtron Int Trading Sarl, Route Molliau 31, CH-1131 Tolochenaz, Switzerland

[4] Medtronic GmbH, Earl Bakken Pl 1, D-40670 Meerbusch, Germany

[5] St Vincenz Hosp Paderborn, Dept Cardiol & Intens Care Med, Busdorf 2, D-33098 Paderborn, Germany

来源：

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH | 2018年 / 7卷 / 05期

关键词：

health economics; medical devices; outcomes research; RISK-FACTORS; IMPLANTATION; MANAGEMENT; MORTALITY;

D O I：

10.2217/cer-2017-0080

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Aim: Estimate incidence and costs of cardiac device infections (CDIs) in Germany. Materials & methods: Patients had an implantable cardioverter defibrillator implanted over 2010-2013 and were followed to December 2014 using German health insurance claims data. A case-controlled analysis was performed using propensity score matching methods. Results: Risk of CDI 12 months post-implant was 3.4% overall, either 2.9% for de novo procedures versus 4.4% for replacement procedures. Mean 3-year incremental expenditure per patient for patients with CDI compared with controls was (sic)31,493 for de novo implant patients and (sic)33,777 for replacement patients. Mean incremental expenditure was (sic)59,419 per patient with a major infection. Conclusion: CDIs are highly expensive to manage, reinforcing the need for strategies to reduce their occurrence.

引用

页码：483 / 492

页数：10

共 23 条

[1] A simple infection-control protocol to reduce serious cardiac device infections [J].